Cardiovascular Implants

Cardiovascular implants, such as stents, heart valves, and occluders, play a critical role in treating life-threatening conditions like coronary artery disease, valvular heart disease, and structural heart defects. Given their high-risk nature and long-term impact on patient health, rigorous clinical trials are essential to ensure safety, efficacy, and durability. These trials typically progress through first-in-human (FIH) studies, pivotal trials, and post-market surveillance, requiring specialized expertise in patient selection, procedural monitoring, and long-term follow-up.

Meditronics (a brand of STEMart) is a leading Contract Research Organization (CRO) specializing in end-to-end clinical trial services for cardiovascular implants. We understand the unique challenges associated with testing stents, heart valves, occluders, and other implantable cardiac devices, and we provide tailored solutions to accelerate regulatory approval and market success.

Our services align with global regulatory requirements, including:

✔ FDA 21 CFR Part 812 (IDE), 814 (PMA), 820 (QSR)

✔ EU MDR (2017/745) & IVDR (2017/746)

✔ ISO 5840 (Cardiovascular Implants - Cardiac Valve Prostheses)

✔ ISO 25539 (Cardiovascular Implants - Endovascular Devices)

✔ ISO 14155 (Clinical Investigation of Medical Devices)

✔ ICH-GCP (Good Clinical Practice)

End-to-End Clinical Trial Services

Strategic Trial Design

Our medical experts develop scientifically robust and regulatory-compliant trial protocols, including:

Endpoint Selection: Balancing clinical outcomes (e.g., mortality, reintervention rates), functional performance, and patient-reported results
Control Group Strategies: Active comparator, historical control, or Objective Performance Criteria (OPC) designs
Risk Mitigation: Data Safety Monitoring Board (DSMB) oversight and rapid adverse event response protocols
Core Lab Services: Angiography, echocardiography, and other imaging assessments

High-Performing Site Selection

Our global database ensures optimal site selection based on:

Site Qualifications: Procedure volume, investigator experience, and IRB efficiency
Geographic Distribution: Ensuring diverse patient representation and faster enrollment
Training & Support: Device implantation training and standardized procedural guidelines
Pre-Study Evaluation: Confirming site capability for complex cardiovascular procedures

Efficient Patient Recruitment

We employ targeted strategies to overcome recruitment challenges:

Electronic Health Record (EHR) Screening: Identifying eligible patients from hospital databases
Physician Referral Networks: Leveraging partnerships with cardiologists
Community Outreach: Early detection of high-risk cardiovascular patients
AI-Powered Prescreening: Enhancing enrollment efficiency
Patient-Friendly Materials: Simplified informed consent tools

Trial Phase	Sample Size Range	Recruitment Strategy
First-in-Human (FIH)	10–30 patients	High-volume cardiac centers, staggered enrollment
Feasibility/Pilot	50–200 patients	EHR screening, physician referral networks
Pivotal RCT	300–1000 patients	AI-powered prescreening, adaptive enrollment
Post-Market (PMS)	1000–5000+ patients	Real-world data (RWD), registry integration

Rigorous Trial Execution

Our operational excellence ensures trial integrity with:

On-Site Monitoring: Clinical research associates overseeing implantation procedures
Device Tracking: Full traceability of implant usage and documentation
Anticoagulation Management: Guidance on perioperative medication protocols
24/7 Medical Support: Rapid response to complications
Source Data Verification: Ensuring accuracy of procedural and imaging records

Long-Term Follow-Up & Outcomes Tracking

Cardiovascular implants require extended monitoring, and we provide:

Multimodal Follow-up: Combining clinic visits, telemedicine, and remote monitoring
Imaging Coordination: Scheduled echocardiograms, CT scans, and other assessments
Therapy Tracking: Monitoring patient adherence and effectiveness
Patient Retention Strategies: Improving follow-up compliance through engagement
Late-Stage Complication Surveillance: Tracking stent thrombosis, valve degeneration, and other critical events

Cardiovascular Implant Categories We Serve

Meditronics tailors its approach based on device type:

Coronary Stents
- Dual antiplatelet therapy (DAPT) protocol design
- Quantitative angiographic analysis for late lumen loss
- Standardized stent thrombosis adjudication
Heart Valves
- Hemodynamic performance evaluation
- Valve-related complication monitoring
- Anticoagulation management
Structural Heart Occluders
- Residual shunt assessment criteria
- Post-procedural conduction disorder tracking
- Device stability monitoring
Left Atrial Appendage (LAA) Occluders
- Device-associated thrombosis evaluation
- Peri-procedural safety monitoring
- Long-term closure efficacy verification

Why Partner with Meditronics for Cardiovascular Implant Trials?

Clinical trials for cardiovascular implants require specialized expertise due to their high-risk nature, complex endpoints, and long-term follow-up requirements. Meditronics offers:

Extensive experience in cardiovascular device trials
A global network of certified cardiac centers
A team of cardiology experts, including interventional cardiologists and cardiac surgeons
Customized risk assessment protocols for implant safety monitoring

Advanced follow-up management systems to ensure long-term data integrity Meditronics provides customized clinical trial solutions for cardiovascular implants at every development stage. Our experts are ready to support your project.

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Need More Information or Request A Quotation?

Send us a request